Category: 2023 Year in Review - Psychedelic Alpha

Access exclusive insights, data and interviews with Pα+: learn more and subscribe today.

Read more about the article The Interdisciplinary Annotated Psychedelic Research Bibliography of 2023

The Interdisciplinary Annotated Psychedelic Research Bibliography of 2023

Post published:February 9, 2024
Post category:2023 Year in Review Analysis

Read more about the article The Psychedelic Drug Development Pipeline: Bullseye Chart Year-End 2023

The Psychedelic Drug Development Pipeline: Bullseye Chart Year-End 2023

Post published:February 6, 2024
Post category:2023 Year in Review Analysis

Read more about the article Psychedelic Policy Reform & Legal Markets in 2023

Psychedelic Policy Reform & Legal Markets in 2023

Post published:January 30, 2024
Post category:2023 Year in Review Analysis

Read more about the article Psychedelics M&A and Partnerships in 2023

Psychedelics M&A and Partnerships in 2023

Post published:January 22, 2024
Post category:2023 Year in Review Analysis

Read more about the article Psychedelic Funding & Public Markets in 2023

Psychedelic Funding & Public Markets in 2023

Post published:January 18, 2024
Post category:2023 Year in Review Analysis

Read more about the article Reflecting on Psychedelics in 2023

Reflecting on Psychedelics in 2023

Post published:January 16, 2024
Post category:2023 Year in Review Analysis

Read more about the article Our Top 10 Psychedelics Articles in 2023

Our Top 10 Psychedelics Articles in 2023

Post published:January 11, 2024
Post category:2023 Year in Review Analysis

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.